Intake Forms for Periodontics Practices: Gum Health History, Implant Planning, and Surgical Risk Assessment
Periodontics occupies a unique position in dentistry. Every patient who walks through your door has already been seen by another provider — a general dentist, a prosthodontist, an oral surgeon who wants a periodontal clearance before proceeding. The referral itself tells you something went wrong, or something complex needs to happen, and the general practice either could not or chose not to handle it in-house. That means your intake process carries a burden that a general dental intake does not: you need to capture not just a baseline health history, but the entire trajectory of a patient’s periodontal condition, the treatments they have already received, the systemic factors that will shape their prognosis, and enough surgical and implant planning detail to begin formulating a treatment sequence before the patient ever sits in your operatory chair.
A generic dental intake form will not accomplish this. General dental forms ask about last cleaning date, flossing habits, and whether the patient grinds their teeth. That information is necessary, but in a periodontal practice it is table stakes — the starting point, not the substance. A periodontal intake form must go several layers deeper because the decisions your practice makes carry higher clinical stakes, longer treatment timelines, greater financial commitment from the patient, and more complicated coordination with referring providers. Here is what that form should capture, and why each section matters for clinical decision-making, risk management, and continuity of care.
Periodontal charting history and baseline documentation
The single most important piece of information a periodontist can have about a new patient is where their periodontal condition stood before they arrived. Probing depths, clinical attachment levels, bleeding on probing, furcation involvement, mobility grades — these measurements taken at the referring dentist’s office, or at a previous periodontist’s practice, establish the trajectory that your own baseline exam will extend. A patient presenting with six-millimeter pockets today tells you one thing if those pockets were three millimeters two years ago and something entirely different if they have been six millimeters for a decade with no further progression.
Your intake form should ask whether the patient has had a full-mouth periodontal charting performed within the past twelve months and, if so, whether those records are available or can be requested from the referring provider. The form should also capture the patient’s own understanding of their condition: have they been told they have gum disease, and if so, when was the first diagnosis? Have they ever been told they have bone loss? Do they recall specific measurements or pocket depths being discussed? Patients are not clinicians, but their recall of past conversations often provides context that clinical records alone do not — particularly when records from a previous provider are incomplete or unavailable.
Equally important is documenting the patient’s home care regimen in enough detail to assess compliance realistically. Asking whether a patient flosses is nearly useless because almost everyone says yes. Asking how many times per week they use interdental cleaning aids, whether they use a manual or powered toothbrush, whether they have ever used an irrigator or prescription rinse, and how long their typical brushing session lasts gives you a compliance profile that correlates with clinical findings. When a patient reports meticulous home care but presents with generalized bleeding on probing and four-to-five-millimeter pockets, you know either the self-report is inaccurate or there is a systemic component driving the inflammation despite adequate mechanical disruption of biofilm.
The intake should also document the patient’s understanding of why they were referred. A patient who knows their general dentist sent them because of progressive attachment loss and deep pockets that did not respond to scaling is psychologically prepared for a treatment conversation that includes surgery. A patient who was told to “go see a gum specialist for a cleaning” arrives with fundamentally different expectations, and knowing that gap exists at the intake stage allows your team to plan the case presentation accordingly rather than discovering the disconnect mid-exam.
The 2017 AAP/EFP classification: staging and grading on intake
Since the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases, the profession has moved from a severity-only system to a staging and grading framework that captures both the current damage and the biological behavior of the disease. Your intake form should be structured to support this classification system because it directly drives treatment planning, prognosis assignment, and insurance documentation.
Staging — from Stage I through Stage IV — reflects the severity and complexity of the case. Stage I represents early periodontitis with one to two millimeters of interdental clinical attachment loss and no tooth loss attributable to periodontal disease. Stage II is moderate, with three to four millimeters of attachment loss, still no periodontal tooth loss, and mostly horizontal bone defects. Stage III introduces severe attachment loss of five millimeters or more, tooth loss due to periodontal breakdown, and complexity factors like vertical bone defects, furcation involvement of Class II or III, and moderate ridge deficiencies. Stage IV adds to Stage III the complicating factors of masticatory dysfunction, secondary occlusal trauma, bite collapse, drifting and flaring, and fewer than twenty remaining teeth. Your intake documentation should include fields or structured sections that allow the clinician to assign a preliminary stage based on the referring records and the patient’s self-reported history, which will then be confirmed or adjusted at the clinical exam.
Grading — A, B, or C — captures the rate of disease progression and the patient’s expected response to therapy. Grade A indicates a slow rate of progression, no evidence of bone loss outpacing what would be expected over time, a non-smoking patient with no diabetes or well-controlled HbA1c below seven percent. Grade B represents moderate progression risk. Grade C is rapid progression, with evidence of bone loss or attachment loss that exceeds what the patient’s age and time since disease onset would predict, often combined with heavy smoking, poorly controlled diabetes, or both. The intake form’s systemic health section directly feeds the grading assignment, which is why capturing smoking history, diabetic status, and HbA1c in structured fields — not just a generic “medical conditions” checkbox — matters so much in a periodontal practice. A Grade C patient on the same stage as a Grade A patient will receive a fundamentally different treatment plan, a more guarded prognosis, and more aggressive recall intervals.
The staging and grading framework also matters for insurance. Predetermination submissions that include a clearly documented stage and grade, supported by clinical attachment level measurements, radiographic bone loss percentages, and documented risk factors, result in fewer denials and faster approvals than submissions that describe the condition in narrative form without referencing the current classification system. Building the classification into your intake workflow means the documentation is captured prospectively rather than reconstructed retroactively when the insurance company asks for supporting evidence.
Bone loss assessment and radiographic history
Radiographic evidence of bone loss is central to periodontal diagnosis and treatment planning, and your intake process should capture what imaging the patient has had and when. A patient arriving with a current full-mouth series or a panoramic radiograph from the referring dentist saves chair time and radiation exposure. A patient whose last radiographs are three years old and were taken at a practice that has since closed presents a documentation gap that your intake should flag immediately, so the clinical team knows to plan imaging into the first appointment rather than discovering the gap mid-exam.
The intake form should ask about the type of imaging performed — periapical series, panoramic, bitewings, cone beam computed tomography — and the approximate date. For patients referred for implant evaluation, CBCT imaging is often necessary, and knowing whether a recent scan exists or whether one needs to be ordered affects scheduling, treatment sequencing, and the referring provider coordination that happens before the patient even arrives. If CBCT has been performed, the form should capture where the scan was taken and whether the DICOM files can be transferred, since re-scanning a patient who already has a diagnostically adequate CBCT from the past six months is both unnecessary and a liability exposure if the re-scan reveals an incidental finding that should have been caught on the original.
Beyond imaging logistics, the form should capture what the patient has been told about their bone loss. Many patients arrive at a periodontist having been told they have “some bone loss” without understanding the severity, distribution, or clinical implications. Documenting their understanding at intake helps calibrate the case presentation conversation. A patient who knows they have lost forty percent of their bone support and understands that certain teeth may not be salvageable is in a different psychological and decision-making position than a patient who was told they “might need to see a specialist” and has no idea what periodontal disease has done to their dentition.
The pattern of bone loss also matters for treatment planning, and while the definitive assessment comes from radiographs, the intake form can capture preliminary indicators. Has the patient been told they have bone loss around specific teeth, or is the loss generalized? Have they been told about vertical or angular defects, or is the loss described as horizontal? Have any teeth been described as having a “poor prognosis” or been recommended for extraction? These patient-reported indicators help the clinician anticipate what the radiographic exam will reveal and prioritize the diagnostic workup accordingly.
Systemic risk factors: smoking, diabetes, and immune compromise
No aspect of the periodontal intake is more clinically consequential than the systemic risk factor assessment, and no aspect is more commonly under-documented. Smoking and diabetes are the two most powerful modifiable risk factors for periodontal disease progression and surgical healing impairment, and they affect nearly every treatment decision a periodontist makes. Your intake form needs to capture these in clinical detail, not as yes-or-no checkboxes.
For tobacco use, the form should document current smoking status, the number of cigarettes or equivalent per day, total pack-years of exposure, and any history of quit attempts or interest in cessation. A patient who smokes half a pack a day has a meaningfully different risk profile than a patient who smokes two packs a day, and both are different from a former smoker who quit five years ago. The distinction matters for prognosis assignment, implant planning, and surgical decision-making. Smoking impairs neutrophil function, reduces gingival blood flow, masks clinical signs of inflammation by suppressing bleeding on probing, and significantly increases the risk of implant failure and post-surgical complications. A periodontist who does not know the patient’s smoking history in detail is making treatment decisions with incomplete data. The form should also ask about other tobacco and nicotine products — cigars, pipe tobacco, smokeless tobacco, vaping devices, and nicotine pouches — because patients who have “quit smoking” may have transitioned to another nicotine delivery system that still impairs periodontal healing through vasoconstriction and altered immune response.
For diabetes, the form should capture the type (Type 1, Type 2, or gestational), the date of diagnosis, the most recent HbA1c value and when it was measured, and the current management regimen including insulin, oral hypoglycemics, and dietary management. An HbA1c above seven percent places the patient in Grade C on the periodontal grading scale and directly affects surgical planning, implant prognosis, and antibiotic prophylaxis decisions. A patient whose diabetes is well-controlled at 6.2 percent presents a vastly different surgical risk than a patient running at 9.5 percent, and the intake form is where you capture that distinction before any treatment decisions are made.
Beyond smoking and diabetes, the form should screen for other conditions that compromise the immune response and affect periodontal disease behavior. HIV/AIDS status and current CD4 count or viral load if known, organ transplant history and current immunosuppressive regimen, autoimmune conditions treated with biologics or corticosteroids, and active cancer treatment including chemotherapy and radiation all affect both disease progression and surgical healing. Head and neck radiation deserves specific attention because it affects salivary function, mucosal integrity, and bone vascularity in ways that directly impact periodontal treatment and implant planning. Osteoporosis and its pharmacological treatment — bisphosphonates and denosumab in particular — warrant their own intake section because of the medication-related osteonecrosis of the jaw risk that these drugs carry, a topic addressed in detail under medication history below.
Implant candidacy evaluation and surgical risk assessment
A significant portion of periodontal referrals are for implant evaluation, and the intake form should capture the information necessary to begin the candidacy assessment before the clinical exam. This includes the location and timing of tooth loss or planned extraction, the reason for tooth loss (periodontal disease, endodontic failure, trauma, caries, congenital absence), and any prior implant experience the patient has had — both successful placements and failures. A patient who lost a previous implant to peri-implantitis has a documented susceptibility that changes the treatment planning conversation for any subsequent implant, and that history needs to be captured at intake rather than discovered mid-treatment.
The surgical risk assessment begins on the intake form with a thorough medical history that goes beyond what a general dental intake requires. Cardiovascular conditions — including hypertension, history of myocardial infarction or stroke, atrial fibrillation, and the presence of cardiac stents or prosthetic valves — affect anesthesia selection, hemostasis management, and antibiotic prophylaxis decisions. The form should capture the specific cardiac condition, the date of the last cardiac event or procedure, and the name of the treating cardiologist, because surgical clearance may need to be obtained before implant placement or osseous surgery can proceed. Similarly, bleeding disorders, whether congenital like hemophilia and von Willebrand disease or acquired through anticoagulant therapy, must be documented in enough detail to plan hemostasis protocols before the surgical appointment rather than improvising in the operatory.
Previous surgical experience in the oral and maxillofacial region is equally important. The form should ask about prior implant surgeries and outcomes, bone grafting procedures using autogenous bone, allograft, xenograft, or synthetic materials, sinus augmentation, ridge augmentation, guided bone regeneration with barrier membranes, and any complications from previous oral surgeries including infection, wound dehiscence, nerve injury, or graft failure. A patient who experienced paresthesia after a previous implant placement in the posterior mandible has a documented nerve vulnerability that changes the imaging requirements, the surgical approach, and the informed consent conversation for any subsequent implant in that region. A patient who had a failed bone graft may need a different graft material, a different surgical technique, or a longer healing timeline, and knowing the history of what was tried and why it failed is essential for planning the next approach with realistic expectations.
The form should also capture the patient’s expectations and understanding of the implant process. Patients frequently arrive at a periodontal consultation expecting a single appointment and a same-day tooth, because that is how implant dentistry is marketed to consumers. Documenting their current understanding of timeline, staged procedures, healing periods, and the potential need for adjunctive procedures like bone grafting, sinus lifts, soft tissue augmentation, and temporary prosthetics at the intake stage allows the clinician to calibrate the case presentation appropriately. When a patient writes on the intake form that they expect to leave with a new tooth today, the clinical team knows before walking into the room that expectation management will be a significant component of the consultation.
Surgical and treatment history in periodontics
A periodontal intake must document every relevant treatment the patient has previously received, because periodontal disease management is cumulative and what has been tried before directly informs what should be recommended next. The form should capture prior scaling and root planing, including how many quadrants were treated, when the procedures were performed, and whether the patient recalls improvement or persistence of symptoms afterward. A patient who had four-quadrant scaling and root planing six months ago and still presents with five-to-six-millimeter pockets and bleeding on probing has already demonstrated that non-surgical therapy alone is insufficient — the treatment conversation begins at a different point than it would for a patient who has never had any periodontal treatment.
The form should document any history of locally delivered antimicrobials such as minocycline microspheres or chlorhexidine chips, and whether systemic antibiotics were prescribed as an adjunct to non-surgical therapy. If antibiotics were used, capturing the specific agent and the clinical response helps inform whether antimicrobial therapy should be part of the current treatment plan or whether the patient’s disease has demonstrated resistance to that approach.
For patients who have undergone periodontal surgery, the form should capture the type of procedure, the approximate date, the treating periodontist if different from your practice, and the outcome as the patient understands it. Osseous surgery with or without osseous recontouring, access flap procedures for debridement, guided tissue regeneration with barrier membranes, connective tissue grafts and free gingival grafts for recession coverage, lateral pedicle grafts, frenectomy, and crown lengthening for restorative or esthetic purposes — each of these tells you something about the severity and trajectory of the patient’s disease, the treatment philosophy of the previous provider, and the patient’s tolerance for surgical intervention. A patient who has undergone multiple surgical procedures and maintained stability for years is a different clinical profile than a first-time referral with the same pocket depths but no treatment history.
Treatment history also includes non-surgical interventions that patients may not think of as periodontal treatment. Occlusal adjustment, night guard fabrication for bruxism and clenching, orthodontic treatment to correct traumatic occlusion or tooth positioning, and splinting of mobile teeth are all relevant to the periodontal picture. A patient whose mobility grades improved with splinting and occlusal equilibration has secondary occlusal trauma as a contributing factor, which affects both the current treatment plan and the long-term prognosis for teeth that might otherwise appear to be extraction candidates based on pocket depths alone.
Medication history: drugs that change periodontal outcomes
Certain medication classes have direct, clinically significant effects on periodontal tissue, surgical healing, and implant osseointegration, and the periodontal intake form must capture them with specificity that goes beyond a general medication list. The most critical categories deserve dedicated sections or structured fields rather than a single open-ended space for listing current medications, because a patient who writes “blood thinner” in a general medications box has given you almost no actionable clinical information.
Anticoagulants and antiplatelet agents represent the most immediately consequential medication category for surgical planning. Warfarin, direct oral anticoagulants like apixaban, rivaroxaban, edoxaban, and dabigatran, heparin and enoxaparin, and antiplatelet agents like clopidogrel, prasugrel, ticagrelor, and aspirin all affect surgical hemostasis differently and require different perioperative management protocols. The intake form should capture the specific agent, the dose, the prescribing physician, and the indication, because the decision about whether to continue, reduce, or temporarily hold anticoagulation before surgery depends entirely on the bleeding risk of the planned procedure weighed against the thrombotic risk of interruption. A patient on apixaban for atrial fibrillation has a different risk calculus than a patient on low-dose aspirin for primary cardiovascular prevention, and the intake form is where you capture the information that drives that decision.
Bisphosphonates and denosumab require their own intake section because of the risk of medication-related osteonecrosis of the jaw. The form should capture the specific drug — alendronate, risedronate, ibandronate, zoledronic acid, or denosumab — the route of administration (oral versus intravenous, which is a critical distinction for MRONJ risk stratification), the duration of therapy in years, and the indication. A patient who has taken oral alendronate for two years for postmenopausal osteoporosis has a meaningfully lower MRONJ risk than a patient who has received intravenous zoledronic acid for bone metastases from breast cancer. Both require caution before any extraction, implant placement, or osseous surgery, but the informed consent conversation, the surgical decision-making, and the perioperative management differ substantially between these scenarios.
Immunosuppressants deserve careful documentation because they affect both periodontal disease progression and surgical healing capacity. Calcineurin inhibitors like cyclosporine and tacrolimus, antimetabolites like mycophenolate and azathioprine, and biologic agents including TNF-alpha inhibitors all impair the immune response in ways that change how aggressively periodontal disease progresses and how reliably surgical sites heal. Cyclosporine is specifically associated with gingival overgrowth that may itself require surgical management, and the intake form should capture the dose and duration because overgrowth severity correlates with drug exposure level. Calcium channel blockers, especially nifedipine and amlodipine, produce similar gingival overgrowth, and when a patient takes both cyclosporine and a calcium channel blocker, the combined effect can be severe enough to warrant a conversation with the prescribing physician about drug substitution before any periodontal surgery is planned.
Phenytoin, used for seizure management, causes drug-induced gingival hyperplasia in a substantial percentage of patients who take it, and the intake form should flag this medication specifically. The clinical presentation of phenytoin-related gingival overgrowth can mimic inflammatory periodontal disease, and a patient referred for “gum disease” who is actually experiencing drug-induced overgrowth without significant attachment loss requires a completely different treatment approach. That differential diagnosis begins with capturing the medication history accurately at intake, not discovering it during the clinical exam when the treatment plan has already been mentally formulated based on incomplete information.
Referral coordination and maintenance recall scheduling
Periodontics is inherently a referral-based specialty, and the intake form should capture the information necessary for seamless coordination with the referring general dentist and any other specialists involved in the patient’s care. The referring dentist’s name, practice, phone number, fax number, and preferred method of communication should be documented, along with whether the patient expects to return to the referring dentist for restorative work following periodontal treatment. For implant cases, the intake should clarify whether the restoring dentist is the same as the referring dentist or a different provider, since implant planning requires input from whoever will be fabricating the final prosthesis about abutment selection, emergence profile, occlusal scheme, and prosthetic platform compatibility.
The form should also ask about other specialists currently involved in the patient’s dental care. An orthodontist who is planning tooth movement needs to know about periodontal limitations that may affect the treatment plan. An endodontist who has performed root canal therapy on a tooth with concurrent periodontal involvement may have information about the prognosis that affects whether the tooth should be retained or extracted. A prosthodontist designing a full-arch rehabilitation needs periodontal input on which teeth can serve as abutments and which cannot. Documenting the full specialist team at intake ensures that your practice can coordinate effectively rather than working in a silo.
The patient’s current maintenance schedule and compliance history deserve their own intake section because maintenance is the determining factor in long-term periodontal stability after active treatment. How often does the patient see their general dentist for prophylaxis? Have they been placed on a three-month, four-month, or six-month recall? Do they keep their appointments consistently, or do they have a pattern of cancellations, no-shows, and extended gaps between visits? A patient who has adhered to a three-month periodontal maintenance schedule for five years demonstrates a compliance pattern that supports an optimistic prognosis. A patient who was told they needed three-month recalls but has not seen a dentist in two years demonstrates a compliance pattern that must be factored into every treatment recommendation, because the most technically perfect surgical outcome will deteriorate without maintenance.
The intake should establish the patient’s understanding of the co-management model that periodontics requires. Many patients do not realize they will alternate between their general dentist and their periodontist for ongoing care, or that periodontal maintenance visits at the specialist’s office are clinically different from a routine prophylaxis at their general dentist. Documenting the patient’s expectations and prior experience with specialty dental care at intake allows the team to address misconceptions early and set realistic expectations about the long-term maintenance commitment. Periodontal disease is managed, not cured, and the patients who achieve the best long-term outcomes are those who understand from the first appointment that they are committing to a structured, indefinite maintenance program rather than a one-time fix.
A well-designed periodontal intake form captures all of this — charting history, disease classification, bone loss documentation, systemic risk factors, implant candidacy data, surgical history, medication interactions, and referral coordination — in a structured, consistent format that clinicians can review efficiently and that integrates into the patient’s permanent record. It saves chair time by front-loading information gathering, reduces the risk of missed risk factors that could compromise treatment outcomes, supports insurance predetermination with classification-based documentation, and provides the medico-legal foundation for informed consent and standard-of-care compliance. If your practice is still using a modified general dental intake, you are leaving clinical information on the table, and eventually that gap will manifest either as a treatment outcome you did not anticipate or a risk factor you did not assess until it was too late to adjust the plan.
Streamline Your Periodontics Intake Process
Templateez offers professionally designed, fillable PDF intake forms and client questionnaires built for healthcare practices. Capture periodontal history, systemic risk factors, surgical documentation, implant candidacy evaluation, and medication interactions — all in a structured format your clinical team can rely on from day one.
Browse All Forms View BundlesNot ready to buy? Download our free Universal Intake Form — a fillable PDF you can use today, no purchase needed.